Staying active, eating healthier and considering medication can help manage hypertension and reduce dementia risk.

Blood biomarker tests for Alzheimer’s disease are increasingly making the jump from research to clinical practice, new ...

It's too late for Lenin, but the University of Pennsylvania's high-resolution MRI scan of a dead person's brain is full of detail. Ex vivo MRI of the brain provides remarkable advantages over in vivo ...

At the 2024 Educational Research and Innovations in Clinical and Health Sciences (ENRICH) Week poster session, Hunter “Caroline” Davies secured first place in the innovation category for her poster, ...

New high-resolution maps of the mouse brain provide researchers with valuable insights into brain development and offer a ...

Synuclein is a protein predominantly associated with neurodegenerative disorders, where its accumulation and aggregation are critical markers of disease progression. In the context of brain aging, ...

(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) Wednesday reported positive interim results from the Phase 1/2 study of its gene therapy candidate LX1001 for the treatment of APOE4-associated Alzheimer's ...

Researchers have discovered that traumatic brain injuries (TBI) may increase the risk of developing Alzheimer’s disease. By examining both brain tissue from animal models and human samples, they ...

PMN310 is an investigational humanized monoclonal antibody (mAb) designed and developed to selectively target soluble amyloid ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Results show CT1812 dramatically slowed cognitive decline in patients with lower levels of plasma p-tau217, an important ...